| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |